2月25日，紫金矿业盘中上涨2.03%，截至10:54，报40.12元/股，成交49.96亿元，换手率0.61%，总市值 10667.80亿元。 资金流向方面，主力资金净流入5.37亿元，特大单买入11.58亿元，占比23.19%，卖出7.72亿元，占比 15.45%；大单买入14.11亿元，占比28.23%，卖出12.60亿元，占比25.22%。 机构持仓方面，截止2025年9月30日，紫金矿业十大流通股东中，香港中央结算有限公司位居第三大流 通股东，持股13.54亿股，相比上期减少2.35亿股。中国证券金融股份有限公司位居第四大流通股东，持 股6.91亿股，持股数量较上期不变。华夏上证50ETF（510050）位居第五大流通股东，持股3.15亿股， 相比上期减少834.77万股。华泰柏瑞沪深300ETF（510300）位居第六大流通股东，持股2.81亿股，相比 上期减少1211.12万股。易方达沪深300ETF（510310）位居第八大流通股东，持股2.03亿股，相比上期 减少647.97万股。 声明：市场有风险，投资需谨慎。本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本文 出现的信息均只作为 ...

2月13日，紫金矿业跌5.01%，截至发稿，报37.76元/股，成交103.52亿元，换手率1.31%，总市值 10040.28亿元。 资料显示，紫金矿业集团股份有限公司位于福建省上杭县紫金大道1号,福建省厦门市思明区环岛东路 1811号中航紫金广场B塔,香港九龙柯士甸道西1号环球贸易广场75楼7503A室，成立日期2000年9月6 日，上市日期2008年4月25日，公司主营业务涉及矿产资源勘查和开发。主营业务收入构成为：冶炼产 品60.94%，矿产品36.48%，其他16.83%，贸易8.02%。 从基金十大重仓股角度 山证资管精选行业混合发起式A（018750）成立日期2023年12月26日，最新规模1096.06万。今年以来收 益25.04%，同类排名85/8890；近一年收益21.91%，同类排名4785/8132；成立以来收益33.77%。 山证资管精选行业混合发起式A（018750）基金经理为庄波。 截至发稿，庄波累计任职时间10年334天，现任基金资产总规模1128.12万元，任职期间最佳基金回报 33.45%， 任职期间最差基金回报-3%。 声明：市场有风险，投资需谨慎。 本文基于第三方数据库 ...

2月初，华盛顿一边在中东继续推进与伊朗的间接接触，谈判地点落在阿曼的消息也陆续被披露，给紧 绷的局势留出一点"喘息缝"。 一旦油更难买，影响会像涟漪一样扩散：先是电网，再是工厂与交通，接着是旅游业的体验与供给稳定 性，最后传导到居民端的生活成本与可获得性。 三、美国在卡谁的脖子：墨西哥与委内瑞拉成了关键节点 要看这份行政令的真实指向，得先看古巴的供油结构。多家报道指向一个事实：2025年墨西哥已成为古 巴最大的原油供应方，委内瑞拉紧随其后，其他来源还包括俄罗斯、阿尔及利亚等。 在委内瑞拉局势骤变、对古巴供给存在不确定性的背景下，美国把"惩罚性关税"这张牌亮出来，本质上 是在逼"沉默的供油者"表态，尤其是让仍在供油的国家承受更直观的对美贸易压力。 另一边，美国在拉美把矛头对准古巴，而且这次不只盯着哈瓦那本身，还把压力顺着供应链甩向第三 国。 一、关税像钳子：把"卖油给古巴"变成高风险生意 1月29日，美国发布一份新的行政令，宣布古巴政府对美国的国家安全与外交构成"特殊威胁"，并以国 家紧急状态为基础，授权对"向古巴出口石油的国家"加征惩罚性关税。政策设计的关键点在于，它瞄准 的不是古巴的进口口岸，而是这些国家进 ...

Core Viewpoint - The stock of Hebang Biotechnology has shown a positive trend with a year-to-date increase of 10.62%, reflecting investor interest and market activity [1]. Group 1: Stock Performance - As of February 11, the stock price of Hebang Biotechnology reached 2.50 CNY per share, with a trading volume of 1.59 billion CNY and a market capitalization of 22.079 billion CNY [1]. - The stock has experienced a 0.81% increase over the last five trading days, a 14.68% increase over the last 20 days, and a 2.46% increase over the last 60 days [1]. - The company has appeared on the "Dragon and Tiger List" once this year, with a net buy of 59.5468 million CNY on January 28, accounting for 14.52% of total trading volume [1]. Group 2: Company Overview - Hebang Biotechnology, established on August 1, 2002, and listed on July 31, 2012, is located in Leshan, Sichuan Province, and specializes in the manufacturing of pesticides, fine chemicals, and various glass products [2]. - The company's revenue composition includes 85.89% from chemical products, 17.61% from photovoltaic glass and other products, 6.74% from mineral products, and 5.02% from other businesses [2]. - The company operates within the basic chemical industry, specifically in the agricultural chemical sector, and is involved in concepts such as chemical raw materials and phosphate chemicals [2]. Group 3: Financial Performance - For the period from January to September 2025, Hebang Biotechnology reported a revenue of 5.927 billion CNY, a decrease of 13.02% year-on-year, and a net profit attributable to shareholders of 93.1085 million CNY, down 57.93% year-on-year [2]. - The company has distributed a total of 1.205 billion CNY in dividends since its A-share listing, with 553 million CNY distributed over the past three years [3]. Group 4: Shareholder Information - As of September 30, 2025, the number of shareholders for Hebang Biotechnology was 196,500, a decrease of 1.99% from the previous period, with an average of 44,939 shares held per shareholder, an increase of 2.03% [2]. - Notable institutional shareholders include Penghua CSI Sub-Sector Chemical Industry Theme ETF and Southern CSI 500 ETF, with significant holdings and changes in share quantities [3].

Core Viewpoint - The Tianjin Customs is set to implement the "Tianjin Customs 24 Measures (2026 Version)" to enhance the city's high-level opening-up and support foreign trade development, following the successful implementation of the previous version [1][2]. Group 1: Policy Implementation - The "Tianjin Customs 24 Measures" will be officially released in early 2024, serving as a key driver for high-quality foreign trade development in Tianjin [1]. - In 2025, Tianjin's total import and export value reached 835.87 billion, with a year-on-year growth of 2.8%, and exports exceeded 400 billion for the first time, reaching 430.94 billion, a 10.1% increase [1]. Group 2: Focus Areas of the New Measures - The new measures will focus on five key areas, including the implementation of national strategies, development of new productive forces, construction of a pioneering reform and opening-up zone, building a modern socialist metropolis, and safeguarding national security [2][3][4]. Group 3: Specific Initiatives - The measures include support for technological innovation tax incentives, expansion of customs clearance for high-tech equipment, and facilitation of cross-border e-commerce [2][3]. - Initiatives to enhance the import and export processes for agricultural products, medical health industries, and high-end manufacturing sectors are also outlined [2][3]. - The establishment of a green channel for the Shanghai Cooperation Organization countries and the promotion of the Belt and Road Initiative are part of the strategic focus [1][2]. Group 4: Security and Safety Measures - The measures emphasize strengthening border security, enhancing the ability to manage public health emergencies, and ensuring food safety at entry points [4].

金元顺安鑫怡混合发起式A（022492）基金经理为李锐、陈铭杰。 截至发稿，李锐累计任职时间339天，现任基金资产总规模1313.64万元，任职期间最佳基金回报 7.68%， 任职期间最差基金回报7.19%。 陈铭杰累计任职时间2年103天，现任基金资产总规模4850.94万元，任职期间最佳基金回报7.68%， 任 职期间最差基金回报-30.43%。 声明：市场有风险，投资需谨慎。 本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本 文出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公告为准。如有疑问，请联系 biz@staff.sina.com.cn。 2月5日，紫金矿业跌5.03%，截至发稿，报37.19元/股，成交56.23亿元，换手率0.72%，总市值9888.72 亿元。 资料显示，紫金矿业集团股份有限公司位于福建省上杭县紫金大道1号,福建省厦门市思明区环岛东路 1811号中航紫金广场B塔,香港九龙柯士甸道西1号环球贸易广场75楼7503A室，成立日期2000年9月6 日，上市日期2008年4月25日，公司主营业务涉及矿产资源勘查和开发。主营业务收入构成为：冶炼产 品60.94% ...

Core Viewpoint - Chip导科技's 2025 annual report reveals a mixed performance with revenue growth but a decline in net profit, while the company plans to expand into automotive electronics through strategic acquisitions [2][5]. Financial Performance - In 2025, Chip导科技 achieved revenue of 394 million yuan, an increase of 11.52% year-on-year [2]. - The net profit attributable to shareholders was 106 million yuan, a decrease of 4.91% compared to the previous year [2]. - The net profit after deducting non-recurring items was 68.89 million yuan, reflecting a growth of 17.54% year-on-year [2]. - The company plans to distribute a cash dividend of 4.30 yuan per 10 shares, totaling 50.57 million yuan, which accounts for 47.64% of the net profit [2]. Business Growth - Chip导科技's power semiconductor sales increased by 25.74% in 2025, driven by robust demand in the consumer electronics sector [3]. - The global semiconductor market is expected to continue its positive trend, with a projected revenue growth of 22.5% in 2025, reaching 772 billion dollars [3]. Research and Development - In 2025, Chip导科技 launched over 150 new power device products and holds a total of 141 valid intellectual property rights [4]. - The company emphasizes its commitment to technological innovation and value creation for customers [4]. Strategic Expansion - Chip导科技 plans to acquire 100% of Jishun Technology and 17.15% of Shunlei Technology, moving towards a Fab-lite model that includes design, packaging, and manufacturing [5]. - The total transaction value for these acquisitions is 403 million yuan, with performance commitments from Shunlei Technology for net profits in the coming years [5]. Industry Outlook - The overall performance of listed companies in the Shanghai market is showing a stable growth trend, particularly in the electronics, basic chemicals, and biopharmaceutical sectors [6]. - Companies like Lanke Technology and Dingtong Technology are also reporting significant profit increases, driven by trends in AI and communication technology [6].

1月30日，和邦生物跌5.24%，成交额13.51亿元。两融数据显示，当日和邦生物获融资买入额1.12亿 元，融资偿还1.51亿元，融资净买入-3902.42万元。截至1月30日，和邦生物融资融券余额合计6.41亿 元。 声明：市场有风险，投资需谨慎。本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本文 出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公告为准。如有疑问，请联系 biz@staff.sina.com.cn。 融资方面，和邦生物当日融资买入1.12亿元。当前融资余额6.32亿元，占流通市值的2.83%，融资余额 超过近一年90%分位水平，处于高位。 责任编辑：小浪快报 截至9月30日，和邦生物股东户数19.65万，较上期减少1.99%；人均流通股44939股，较上期增加 2.03%。2025年1月-9月，和邦生物实现营业收入59.27亿元，同比减少13.02%；归母净利润9310.85万 元，同比减少57.93%。 分红方面，和邦生物A股上市后累计派现12.05亿元。近三年，累计派现5.53亿元。 机构持仓方面，截止2025年9月30日，和邦生物十大流通股东中，鹏华中证细分化 ...

交银智选星光混合(FOF-LOF)A（501210）基金经理为刘兵。 截至发稿，刘兵累计任职时间4年153天，现任基金资产总规模16.37亿元，任职期间最佳基金回报 53.13%， 任职期间最差基金回报-12.13%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 责任编辑：小浪快报 1月22日，和邦生物涨5.35%，截至发稿，报2.56元/股，成交2.25亿元，换手率1.03%，总市值226.09亿 元。和邦生物股价已经连续3天上涨，区间累计涨幅9.46%。 资料显示，四川和邦生物科技股份有限公司位于四川省乐山市五通桥区牛华镇沔坝村，成立日期2002年 8月1日，上市日期2012年7月31日，公司主营业务涉及农药及农药中间体制造、精细化工产品制造、智 能玻璃、特种玻璃制造及纯碱、氯化铵制造及盐矿、磷矿的开发。主营业务收入构成为：化学产品 85.89%，光伏玻璃及其他产品17.61%，矿产品6.74%，其他业务5.02%。 从基金十大重仓股角度 数据显示，交银施罗德基金 ...

Core Insights - The Hainan Free Trade Port has fully implemented its closure policies, including "zero tariffs," tax exemptions for processing and value-added goods, and relaxed trade management measures, significantly enhancing its attractiveness for investment and trade [3][5]. Group 1: Policy Implementation - The "zero tariff" policy has been expanded, with 30 entities importing zero-tariff goods worth 750 million yuan, covering 37 product categories, primarily including crude oil and mineral products [5]. - The processing and value-added tax exemption policy has shown significant effects, with 30 companies exporting goods worth 85.87 million yuan, resulting in a tax exemption of 3.318 million yuan, mainly in the chemical, medical, and food sectors [5]. - Trade management measures have been relaxed, allowing for breakthroughs in the import of bonded maintenance goods valued at 347,000 yuan [5]. Group 2: Consumer Activity - The demand for duty-free shopping has surged, with the total amount of duty-free shopping monitored by customs reaching 4.86 billion yuan, with 745,000 shoppers and 3.494 million items purchased, reflecting increases of 95.2%, 57.4%, and 68.6% respectively [5]. - The sales of electronic consumer products have become a major driver, with sales reaching 22.74 million yuan, catering to diverse shopping needs [5]. - The new "immediate purchase and pick-up" policy has led to shopping amounts of 28.87 million yuan from local residents, marking a 28.2% increase [5]. Group 3: Economic Activity - The release of policy benefits has boosted market confidence, with the number of approved entities enjoying "zero tariffs" reaching 10,038 and 112 companies registered for processing and value-added tax exemptions [5]. - A total of 5,132 new foreign trade enterprises have been registered, including 113 new foreign-invested companies, marking a historic milestone with over 100,000 registered enterprises [5]. - Preliminary statistics indicate that Hainan's total foreign trade import and export value has exceeded 27 billion yuan [5].